CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.29 USD
-0.02 (-1.53%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $1.30 +0.01 (0.78%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for CoDiagnostics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -35.33 | -14.24 | 36.66 | 42.48 | -6.20 |
Depreciation/Amortization & Depletion | 1.23 | 16.67 | 0.34 | 0.14 | 0.07 |
Net Change from Assets/Liabilities | 5.64 | 6.37 | -2.90 | -16.82 | -0.82 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.38 | -2.24 | 6.98 | 2.37 | 1.42 |
Net Cash From Operating Activities | -22.08 | 6.57 | 41.08 | 28.17 | -5.53 |
Property & Equipment | -1.37 | -1.43 | -0.67 | -0.77 | -0.11 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 1.20 | 0.00 | 0.00 |
Investments | 16.75 | -56.74 | 3.57 | -5.05 | -0.32 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 15.39 | -58.17 | 4.10 | -5.82 | -0.44 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1.36 | -14.03 | 0.45 | 21.20 | 6.50 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -1.46 | -0.59 |
Net Cash from Financing Activities | -1.36 | -14.03 | 0.45 | 19.74 | 5.90 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -8.06 | -65.63 | 45.63 | 42.08 | -0.06 |
Cash at Beginning of Period | 22.97 | 88.61 | 42.98 | 0.89 | 0.95 |
Cash at End of Period | 14.92 | 22.97 | 88.61 | 42.98 | 0.89 |
Diluted Net EPS | -1.20 | -0.45 | 1.23 | 1.52 | -0.36 |
Fiscal Year End for CoDiagnostics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -16.91 | -9.31 | -35.33 | -20.66 | -14.67 |
Depreciation/Amortization & Depletion | 0.67 | 0.33 | 1.23 | 0.92 | 0.62 |
Net Change from Assets/Liabilities | -0.21 | -0.52 | 5.64 | 5.15 | 4.64 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.76 | 1.01 | 6.38 | -2.71 | -1.30 |
Net Cash From Operating Activities | -13.69 | -8.49 | -22.08 | -17.30 | -10.71 |
Property & Equipment | -0.50 | -0.40 | -1.37 | -0.90 | -0.66 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 13.14 | 17.08 | 16.75 | 6.67 | 3.27 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 12.64 | 16.67 | 15.39 | 5.77 | 2.60 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | -1.36 | -1.20 | -1.04 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.00 | 0.00 | -1.36 | -1.20 | -1.04 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.06 | 8.18 | -8.06 | -12.73 | -9.14 |
Cash at Beginning of Period | 14.92 | 14.92 | 22.97 | 22.97 | 22.97 |
Cash at End of Period | 13.86 | 23.10 | 14.92 | 10.24 | 13.83 |
Diluted Net EPS | -0.25 | -0.31 | -0.49 | -0.20 | -0.31 |